Announced Mon, 6 Jul · 19:04 IST
Sun Pharma 34th AGM Notice and FY26 Annual Report filed
Board & Shareholder Meetings View source PDF
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.4%1-day move
₹1913.60
prior close
₹1900.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.4+0.6+0.8-1.4+1.4+1.0+0.4+1.6+2.0————
Up moveDown movePending
AI summary
Sun Pharma filed the 34th AGM Notice and FY 2025-26 Annual Report under SEBI LODR. The AGM is on 31 July 2026 at 4:00 PM via video conferencing. E-voting runs 27-30 July; 24 July is the cut-off. FY26 highlights: consolidated revenue up 11.9 percent to ₹582 Billion, EBITDA up 16.1 percent to ₹177 Billion, net profit up 5 percent to ₹115 Billion. Innovative Medicines contribute 22 percent of sales. Kirti Ganorkar is the new Managing Director.
Likely market impact
Routine AGM filing. FY26 shows healthy revenue and profit growth. Shareholders can vote remotely 27-30 July. Leadership transition with Kirti Ganorkar as new MD.